1. Home
  2. TPH vs SUPN Comparison

TPH vs SUPN Comparison

Compare TPH & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tri Pointe Homes Inc.

TPH

Tri Pointe Homes Inc.

HOLD

Current Price

$33.66

Market Cap

2.8B

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$48.76

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TPH
SUPN
Founded
2009
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.8B
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
TPH
SUPN
Price
$33.66
$48.76
Analyst Decision
Buy
Strong Buy
Analyst Count
6
5
Target Price
$41.40
$61.60
AVG Volume (30 Days)
763.1K
634.0K
Earning Date
02-25-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.42
N/A
Revenue
$3,751,941,000.00
$681,539,000.00
Revenue This Year
N/A
$8.16
Revenue Next Year
N/A
$23.82
P/E Ratio
$9.73
N/A
Revenue Growth
N/A
4.54
52 Week Low
$27.90
$29.16
52 Week High
$38.73
$57.65

Technical Indicators

Market Signals
Indicator
TPH
SUPN
Relative Strength Index (RSI) 50.12 44.83
Support Level $34.05 $47.94
Resistance Level $34.17 $50.09
Average True Range (ATR) 1.09 1.55
MACD -0.16 -0.29
Stochastic Oscillator 22.29 20.39

Price Performance

Historical Comparison
TPH
SUPN

About TPH Tri Pointe Homes Inc.

Tri Pointe Homes Inc is an American construction company that focuses on residential construction. The company is engaged in the design, construction, and sale of single-family attached and detached homes in different states across the United States. Its operations are organized into two principal businesses: homebuilding. which generates key revenue, and financial services. The homebuilding business has three reportable operating segments, based on the geographical layout of the markets, and includes West region, Central region, and East region. The company's financial services operation is comprised of its Tri Pointe Connect mortgage financing operations, Tri Pointe Assurance title and escrow services operations, and Tri Pointe Advantage property and casualty insurance agency operations.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: